VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...

Oral agent in second-line more than doubled median PFS in patients with ESR1 muta ...

Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

Advanced cardiovascular-kidney-metabolic (CKM) syndrome stage, especially stages 3 and 4, is associated with increased cancer risk.

Read full article: Virginia Tech sophomore starts foundation to assist Carilion Clinic’s new Cancer Center But first they all pitched in to build handicapped access ramps. 51 minutes ago Renovation ...

New findings suggest that melanoma does not behave uniformly across the lifespan, with immune defenses and tumor activity ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...

PRISM coaching improved hope, resilience, and quality of life in AYAs with advanced cancer, with lasting benefits on anxiety and care engagement. The program includes four individual sessions and a ...

Please provide your email address to receive an email when new articles are posted on . Many patients with advanced cancer receive treatments focused on longevity, even if they prioritize comfort.

Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...

A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding ...